『Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseases』のカバーアート

Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseases

Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseases

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 Ehsan Rahimy, MD; David G. Miller, MD, Esther Kim, MD, discusses how achieving retinal drying through anti-VEGF therapies remains a critical marker of treatment success in retinal diseases like AMD and DME, while highlighting the benefits of newer agents like aflibercept 8mg and faricimab for providing better durability and sustained disease control with reduced treatment burden.

Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseasesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。